{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:35:41Z","timestamp":1761233741848,"version":"build-2065373602"},"reference-count":10,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"DOI":"10.1182\/blood.2025030493","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:32:15Z","timestamp":1761233535000},"page":"2014-2016","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Patient-specific enhancers in genetically uniform leukemias"],"prefix":"10.1182","volume":"146","author":[{"given":"Tim","family":"Kong","sequence":"first","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"17","key":"2025102311320716800_bib1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/blood.2024028019","article-title":"Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients","volume":"146","author":"Smith","year":"2025","journal-title":"Blood"},{"issue":"9321","key":"2025102311320716800_bib2","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"2025102311320716800_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"issue":"7","key":"2025102311320716800_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1101\/gr.268490.120","article-title":"A KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes","volume":"31","author":"Harman","year":"2021","journal-title":"Genome Res"},{"issue":"R2","key":"2025102311320716800_bib5","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1093\/hmg\/ddy167","article-title":"Enhancers: bridging the gap between gene control and human disease","volume":"27","author":"Karnuta","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"16","key":"2025102311320716800_bib6","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2017-11-737379","article-title":"Enhancer dysfunction in leukemia","volume":"131","author":"Bhagwat","year":"2018","journal-title":"Blood"},{"issue":"7986","key":"2025102311320716800_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-023-06682-5","article-title":"Epigenetic regulation during cancer transitions across 11 tumour types","volume":"623","author":"Terekhanova","year":"2023","journal-title":"Nature"},{"issue":"10","key":"2025102311320716800_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat Rev Genet"},{"key":"2025102311320716800_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2025102311320716800_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1182\/blood-2015-07-604512","article-title":"Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia","volume":"127","author":"Wouters","year":"2016","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/17\/2014\/2417511\/blood_bld-2025-030493-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/17\/2014\/2417511\/blood_bld-2025-030493-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:32:16Z","timestamp":1761233536000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/17\/2014\/547799\/Patient-specific-enhancers-in-genetically-uniform"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":10,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,10,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025030493","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,23]]},"published":{"date-parts":[[2025,10,23]]}}}